loading
Precedente Chiudi:
$26.26
Aprire:
$26.62
Volume 24 ore:
461.41K
Relative Volume:
0.38
Capitalizzazione di mercato:
$1.77B
Reddito:
$5.79M
Utile/perdita netta:
$-199.61M
Rapporto P/E:
-8.8771
EPS:
-3.01
Flusso di cassa netto:
$-188.48M
1 W Prestazione:
-0.41%
1M Prestazione:
+4.37%
6M Prestazione:
+36.47%
1 anno Prestazione:
-5.01%
Intervallo 1D:
Value
$26.18
$26.77
Intervallo di 1 settimana:
Value
$25.97
$28.59
Portata 52W:
Value
$14.40
$29.38

Celldex Therapeutics Inc Stock (CLDX) Company Profile

Name
Nome
Celldex Therapeutics Inc
Name
Telefono
908-200-7500
Name
Indirizzo
53 FRONTAGE ROAD, HAMPTON
Name
Dipendente
186
Name
Cinguettio
@search?q=celldex
Name
Prossima data di guadagno
2024-11-04
Name
Ultimi documenti SEC
Name
CLDX's Discussions on Twitter

Confronta CLDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CLDX
Celldex Therapeutics Inc
26.72 1.74B 5.79M -199.61M -188.48M -3.01
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
421.39 108.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
463.43 60.82B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.95 61.02B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
817.32 50.01B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
310.81 34.05B 4.56B -176.77M 225.30M -1.7177

Celldex Therapeutics Inc Stock (CLDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-21 Iniziato Mizuho Outperform
2025-10-13 Iniziato Barclays Underweight
2025-04-28 Iniziato Canaccord Genuity Buy
2025-03-20 Iniziato Morgan Stanley Overweight
2025-02-13 Iniziato UBS Buy
2024-10-07 Iniziato Citigroup Buy
2024-09-30 Iniziato Goldman Neutral
2024-09-27 Downgrade Wolfe Research Outperform → Peer Perform
2024-06-18 Iniziato Stifel Buy
2024-06-11 Iniziato Wolfe Research Outperform
2023-12-20 Iniziato TD Cowen Outperform
2023-11-10 Aggiornamento Wells Fargo Underweight → Equal Weight
2023-08-22 Iniziato Wells Fargo Underweight
2021-09-17 Iniziato Jefferies Buy
2021-09-10 Iniziato SVB Leerink Outperform
2021-07-22 Iniziato Guggenheim Buy
2020-02-21 Iniziato Cantor Fitzgerald Overweight
2017-08-01 Ripresa H.C. Wainwright Buy
2016-11-07 Iniziato Aegis Capital Buy
2016-03-08 Downgrade Jefferies Buy → Hold
2016-03-07 Downgrade Guggenheim Buy → Neutral
2016-03-07 Downgrade Leerink Partners Outperform → Mkt Perform
2016-03-07 Downgrade Wedbush Outperform → Neutral
2016-03-01 Iniziato H.C. Wainwright Buy
2015-08-11 Reiterato Brean Capital Buy
2015-08-11 Reiterato Oppenheimer Outperform
2015-08-11 Reiterato ROTH Capital Buy
2015-06-02 Reiterato WBB Securities Strong Buy
2014-11-17 Reiterato ROTH Capital Buy
2014-03-04 Reiterato Oppenheimer Outperform
2013-07-08 Reiterato Cantor Fitzgerald Buy
2013-03-08 Reiterato Cantor Fitzgerald Buy
2013-02-26 Reiterato Oppenheimer Outperform
2013-01-10 Reiterato Cantor Fitzgerald Buy
2012-10-02 Reiterato Oppenheimer Outperform
2012-09-14 Reiterato Cantor Fitzgerald Buy
Mostra tutto

Celldex Therapeutics Inc Borsa (CLDX) Ultime notizie

pulisher
05:09 AM

Can Celldex Therapeutics Inc. stock reach $100 price targetMarket Activity Recap & Free Daily Entry Point Trade Alerts - newser.com

05:09 AM
pulisher
03:28 AM

Real time alert setup for Celldex Therapeutics Inc. performanceTrade Analysis Report & Real-Time Volume Surge Alerts - newser.com

03:28 AM
pulisher
03:19 AM

What’s next for Celldex Therapeutics Inc. stock priceForecast Cut & Advanced Technical Analysis Signals - newser.com

03:19 AM
pulisher
02:59 AM

Is it too late to sell Celldex Therapeutics Inc.2025 Volatility Report & Growth Focused Entry Point Reports - newser.com

02:59 AM
pulisher
02:33 AM

Published on: 2025-10-26 01:33:16 - newser.com

02:33 AM
pulisher
02:22 AM

Published on: 2025-10-26 01:22:51 - newser.com

02:22 AM
pulisher
01:54 AM

Why analysts remain bullish on Celldex Therapeutics Inc. stock2025 Pullback Review & Verified Momentum Watchlists - newser.com

01:54 AM
pulisher
01:01 AM

What momentum shifts mean for Celldex Therapeutics Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - newser.com

01:01 AM
pulisher
12:41 PM

Will Celldex Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Action & Verified Entry Point Detection - newser.com

12:41 PM
pulisher
Oct 25, 2025

Is Celldex Therapeutics Inc. stock a bargain at current levelsPortfolio Update Summary & Safe Capital Growth Tips - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Chart overlay techniques for tracking Celldex Therapeutics Inc.Weekly Investment Recap & Community Verified Trade Alerts - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

How Celldex Therapeutics Inc. (TCE2) stock trades in high volatilityMarket Movers & Verified Technical Signals - newser.com

Oct 25, 2025
pulisher
Oct 25, 2025

Published on: 2025-10-25 02:57:01 - newser.com

Oct 25, 2025
pulisher
Oct 24, 2025

Published on: 2025-10-24 02:30:04 - newser.com

Oct 24, 2025
pulisher
Oct 23, 2025

Celldex Therapeutics Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Oct 23, 2025
pulisher
Oct 23, 2025

Published on: 2025-10-23 07:06:05 - newser.com

Oct 23, 2025
pulisher
Oct 23, 2025

Celldex Therapeutics (CLDX): Evaluating Valuation After Barclays' Underweight Rating and Industry Concerns - Yahoo Finance

Oct 23, 2025
pulisher
Oct 22, 2025

Celldex Therapeutics Receives Bullish Analyst Coverage Amid Pipeline Developments - AD HOC NEWS

Oct 22, 2025
pulisher
Oct 22, 2025

Will Celldex Therapeutics Inc. (TCE2) stock hit Wall Street targetsJobs Report & High Return Trade Guides - newser.com

Oct 22, 2025

Celldex Therapeutics Inc Azioni (CLDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.26
price up icon 1.11%
$91.28
price up icon 2.21%
$29.89
price up icon 0.07%
$105.66
price up icon 0.87%
$159.66
price down icon 0.29%
biotechnology ONC
$310.81
price up icon 0.25%
Capitalizzazione:     |  Volume (24 ore):